Evidence map›Paper›PMID 20974981›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes.

Keigo Machida, George McNamara, Kevin T-H Cheng, Jeffrey Huang, Chun-Hsiang Wang, Lucio Comai, Jing-Hsiung James Ou, Michael M C Lai

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 99 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Leukemic conversion involvingFrontiers in oncology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Keigo MachidaDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. kmachida@usc.edu
George McNamara
Kevin T-H Cheng
Jeffrey Huang
Chun-Hsiang Wang
Lucio Comai
Jing-Hsiung James Ou
Michael M C Lai
University of Southern California · USChildren's Hospital of Los Angeles · USResearch Center for Applied Science, Academia Sinica · TW

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANNA S. GUKOVSKAYA · 1999 to 2026
$45.8M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAMM-ALVAREZ, SARAH F · 1995 to 2020
$21.8M
TRIM mediated host antiviral responses during influenza virus infectionsU19AI083025 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2009 to 2013
$10.0M
Virus-host interactions in hepatocarcinogenesisP01CA123328 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, MICHAEL M.C. · 2007 to 2011
$5.3M
TRANSGENIC MICE AS A MODEL TO STUDY HEPATITIS C VIRUS IMMUNOPATHOGENESISU19AI040038 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, MICHAEL M.C. · 1996 to 2004
$3.8M
Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCVR01AA018857 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACHIDA, KEIGO · 2009 to 2013
$1.8M
CELL CULTURE-BASED STUDIES OF HCV PATHOGENESISR01CA108302 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, MICHAEL M.C. · 2003 to 2007
$1.6M
NCI NIH HHS CA108302NCI NIH HHS CA123328NCI NIH HHS P01 CA123328NCI NIH HHS R01 CA108302NIAAA NIH HHS 1R01AA018857-01NIAAA NIH HHS P50 AA011999NIAAA NIH HHS P50AA11999NIAAA NIH HHS R01 AA018857NIAID NIH HHS AI 40038NIAID NIH HHS N01 AI040038NIAID NIH HHS U19 AI083025NIDDK NIH HHS 5P30DK048522-13NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection is associated with the development of hepatocellular carcinoma and putatively also non-Hodgkin's B cell lymphoma. In this study, we demonstrated that PBMCs obtained from HCV-infected patients showed frequent chromosomal aberrations and that HCV infection of B cells in vitro induced enhanced chromosomal breaks and sister chromatid exchanges. HCV infection hypersensitized cells to ionizing radiation and bleomycin and inhibited nonhomologous end-joining repair. The viral core and nonstructural protein 3 proteins were shown to be responsible for the inhibition of DNA repair, mediated by NO and reactive oxygen species. Stable expression of core protein induced frequent chromosome translocations in cultured cells and in transgenic mice. HCV core protein binds to the NBS1 protein and inhibits the formation of the Mre11/NBS1/Rad50 complex, thereby affecting ATM activation and inhibiting DNA binding of repair enzymes. Taken together, these data indicate that HCV infection inhibits multiple DNA repair processes to potentiate chromosome instability in both monocytes and hepatocytes. These effects may explain the oncogenicity and immunological perturbation of HCV infection.

Indexed as

Acid Anhydride HydrolasesAnimalsAtaxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TransformedCell Line, TumorCells, CulturedDNA-Binding ProteinsDNA DamageDNA RepairDNA Repair EnzymesHEK293 CellsHepacivirusHepatocytesHep G2 CellsAcid Anhydride HydrolasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseCell Cycle ProteinsDNA-Binding ProteinsDNA Repair EnzymesMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNHEJ1 protein, humanNuclear Proteinsnucleocapsid protein, Hepatitis C virusProtein Serine-Threonine KinasesRAD50 protein, humanReactive Nitrogen SpeciesReactive Oxygen SpeciesTumor Suppressor ProteinsViral Core Proteins

Identifiers

PMID20974981
PMCPMC3101474
OpenAlexW1618773271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.